Home >
Medicine Info >
Ornigyl 500 mg Infusion
Loading interface...

Ornigyl 500 mg Infusion

Manufactured byJb Chemicals And Pharmaceuticals Ltd.
ContainsOrnidazole
Description
Ornigyl 500 mg Infusion is an antiprotozoal and antibacterial agent, which is used for treating the severe infections of the gastrointestinal tract, urinary tract, genital areas, etc caused by susceptible anaerobic bacteria or amoeba. It is also used for the prevention of post-operative infections.
QUICK LINKS:
Side effectsConcernsUsage

Substitutes

List of substitutes for Ornigyl 500 mg Infusion

Dazolic 500 mg Infusion
Sun Pharma Laboratories Ltd.
Ornida 500 mg Infusion
Aristo Pharmaceuticals Pvt. Ltd.

Side effects

Major & minor side effects for Ornigyl 500 mg Infusion

  • Headache
  • Nausea and Vomiting
  • Dizziness
  • Change in pulse rate
  • Abdominal pain
  • Unusual tiredness and weakness
  • Shaking of the hands or feet
  • Skin rash and itching
  • Red spots on skin
  • Abnormal Liver function

Uses of Ornigyl 500 mg Infusion

What is it prescribed for?

  • Anaerobic bacterial infections
  • Surgical prophylaxis
  • Amoebic Liver Abscess
  • Severe amoebic dysentery
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during the treatment with this medicine due to the increased risk of severe adverse effects. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is contraindicated for use in the first trimester of pregnancy. It can be used in the second and third trimesters of pregnancy only if clearly needed. All the risks and benefits should be discussed with the doctor before receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition

Allergy

This medicine is not recommended for use in patients with a known allergy to ornidazole, other nitroimidazoles, or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is contraindicated for use in the first trimester of pregnancy. It can be used in the second and third trimesters of pregnancy only if clearly needed. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition
General warnings

Kidney/Liver Disease

This medicine should be used with caution in patients having an impairment of the kidney/liver function. due to the increased risk of adverse effects. Regular monitoring of kidney/liver function is necessary for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Epilepsy

This medicine should be used with caution in patients suffering from epilepsy or other convulsion disorders due to the increased risk of adverse effects. Report any unusual symptoms to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Blood cell count

Use of this medicine may lower the blood cell count and may lead to leukopenia, thrombocytopenia, and bone marrow aplasia. Close monitoring of WBC count, platelets is necessary. Discontinue the treatment if any signs of low blood cell count appear.

Driving or Operating machinery

Use of this medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Multiple sclerosis

This medicine should be used with extreme caution in patients suffering from this neurodegenerative disorder of the brain due to the increased risk of adverse effects. Report any unusual symptoms to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during the treatment with this medicine due to the increased risk of severe adverse effects. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Vecuronium

Warfarin

Disease interactions

Kidney Disease

This medicine should be used with caution in patients with kidney diseases due to the increased risk of serious adverse effects. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Liver Disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of serious adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by inhibiting the growth of protozoa or bacteria by interfering with the protein formation process leading to cell lysis.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Antiprotozoals, Miscellaneous antibiotics

Schedule

Schedule H

Maxzole [Internet]. Maxpharma.com.np. 2019 [cited 10 October 2019]. Available from:

http://maxpharma.com.np/product-detail/maxzole.html

Ornidazole | C7H10ClN3O3 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 1 June 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/28061#section=Top
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 17 Oct 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.